Member access

4-Traders Homepage  >  Shares  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( CHF)
Sales 2015 48 036 M
EBIT 2015 17 098 M
Net income 2015 11 294 M
Debt 2015 9 484 M
Yield 2015 2,96%
Sales 2016 50 204 M
EBIT 2016 18 287 M
Net income 2016 12 328 M
Debt 2016 5 260 M
Yield 2016 3,16%
PER 2015 20,82
PER 2016 19,04
EV / Sales 2015 5,22x
EV / Sales 2016 4,91x
Capitalization 241 449 M
More Financials
Company
Roche Holding AG operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics.It operates business through two divisons: Pharmaceuticals and Diagnostics.The Pharmaceuticals divison comprises the two business segments Roche Pharmaceuticals and Chugai,... 
Sector
Pharmaceuticals
Calendar
05/27 | 09:00amPresentation
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
05/27 ROCHE : Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop..
05/15DJEUROPE MARKETS : European Stocks Erase Draghi-inspired Gains After Weak U.S. Dat..
05/15DJEUROPE MARKETS : European Stocks Build On Draghi-inspired Gains
05/15DJEUROPE MARKETS : European Stocks Build On Draghi-inspired Gains
05/15DJEUROPE MARKETS : European Stocks Build On Draghi-inspired Gains
05/13DJPharma Industry Needs Billions of Dollars for Antibiotics Research
05/13 ROCHE : Genentech :’s Investigational Immunotherapy MPDL3280A Doubled the ..
05/13 ROCHE : Genentech :’s Investigational Medicine Alectinib Shrank Tumors in ..
More news
Sector news : Pharmaceuticals - NEC
05:54pDJMerck Submits New Drug Application for Hepatitis Combination
04:34p MERCK : Submits U.S. New Drug Application for Grazoprevir/Elbasvir, an Investiga..
04:12p BAYER : Returns to Nigeria, Floats New Firm
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions